-
Posted: August 14th, 2015, 2:00am GMT
Conditions: Langerhans Cell Histiocytosis (LCH); Histiocytoses Erdheim-chester Disease; Histiocytic Sarcoma (HS)
Interventions: Drug: Lenalidomide
Sponsors: Dana-Farber Cancer Institute; Celgene
Active, not recruiting
-
Posted: July 24th, 2015, 2:00am GMT
Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Syndrome; Rhabdomyosarcoma; Ewing Sarcoma; Primitive Neuroectodermal Tumor; Osteosarcoma; Neuroblastoma
Interventions: Procedure: TCRαβ+/CD19+ depleted Haploidentical HSCT; Drug: Zoledronate
Sponsors: University of Wisconsin, Madison
Recruiting
-
Posted: July 20th, 2015, 2:00am GMT
Conditions: Recurrent Osteosarcoma
Interventions: Biological: humanized anti-GD2 antibody; Drug: GM-CSF
Sponsors: Memorial Sloan Kettering Cancer Center; Children's Hospital Los Angeles; M.D. Anderson Cancer Center; Y-mAbs Therapeutics
Recruiting
-
Posted: June 12th, 2015, 2:00am GMT
Conditions: Metastatic Osteosarcoma; Recurrent Osteosarcoma; Refractory Osteosarcoma; Stage IV Osteosarcoma AJCC v7; Stage IVA Osteosarcoma AJCC v7; Stage IVB Osteosarcoma AJCC v7
Interventions: Biological: Denosumab; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Completed
-
Posted: May 22nd, 2015, 2:00am GMT
Conditions: Soft Tissue Sarcoma
Interventions: Drug: Olaratumab; Drug: Doxorubicin; Drug: Placebo
Sponsors: Eli Lilly and Company
Active, not recruiting
-
Posted: May 4th, 2015, 2:00am GMT
Conditions: Adult Solid Neoplasm; Bladder Carcinoma; Colon Carcinoma; Estrogen Receptor Negative; Head and Neck Squamous Cell Carcinoma; Hepatocellular Carcinoma; HER2/Neu Negative; Melanoma; Non-Small Cell Lung Carcinoma; Pancreatic Carcinoma; Progesterone Receptor Negative; Rectal Carcinoma; Renal Cell Carcinoma; Soft Tissue Sarcoma; Triple-Negative Breast Carcinoma; TP53 Gene Mutation; Unresectable Solid Neoplasm
Interventions: Other: Laboratory Biomarker Analysis; Biological: Modified Vaccinia Virus Ankara Vaccine Expressing p53; Biological: Pembrolizumab
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Active, not recruiting
-
Posted: April 6th, 2015, 2:00am GMT
Conditions: Advanced Malignant Solid Neoplasm; Anal Carcinoma; HIV Infection; Kaposi Sarcoma; Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Recurrent Classic Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma; Unresectable Solid Neoplasm
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Biological: Ipilimumab; Biological: Nivolumab; Procedure: Positron Emission Tomography
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: March 18th, 2015, 2:00am GMT
Conditions: Neurofibroma, Plexiform; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Promyelocytic, Acute; Sarcoma
Interventions: Drug: TURALIO(R)
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: March 10th, 2015, 2:00am GMT
Conditions: Adult Soft Tissue Sarcoma; Bone Sarcoma; Retroperitoneal Sarcoma
Interventions: Procedure: Real-Time CEUS; Procedure: SWE; Drug: Definity Suspension for Injection; Device: Philips Shear Wave Elastography
Sponsors: University of Southern California; National Cancer Institute (NCI)
Completed
-
Posted: May 5th, 2014, 2:00am GMT
Conditions: Advanced Cancer
Interventions: Radiation: FDG
Sponsors: Weill Medical College of Cornell University
Suspended
-
Posted: April 1st, 2014, 2:00am GMT
Conditions: Ewing Sarcoma; Neuroblastoma; Rhabdomyosarcoma; Osteosarcoma; CNS Tumors
Interventions: Procedure: Allogeneic HCT; Drug: Donor NK Cell Infusion
Sponsors: Monica Thakar
Completed
-
Posted: December 16th, 2013, 3:00am GMT
Conditions: Pancreatic Cancer; Thyroid Cancer; Lung Cancer; Esophageal Cancer; Thymus Cancer; Colon Cancer; Rectal Cancer; Gastrointestinal Stromal Tumors; Anal Cancer; Bile Duct Cancer; Duodenal Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Small Intestine Cancer; Peritoneal Surface Malignancies; Familial Adenomatous Polyposis; Lynch Syndrome; Bladder Cancer; Kidney Cancer; Penile Cancer; Prostate Cancer; Testicular Cancer; Ureter Cancer; Urethral Cancer; Hypopharyngeal Cancer; Laryngeal Cancer; Lip Cancer; Oral Cavity Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; Paranasal Sinus Cancer; Nasal Cavity Cancer; Salivary Gland Cancer; Skin Cancer; Central Nervous System Tumor; Central Nervous System Cancer; Mesothelioma; Breast Cancer; Leukemia; Melanoma; Sarcoma; Unknown Primary Tumor; Multiple Myeloma; Ovarian Cancer; Endometrial Cancer; Vaginal Cancer; Neuroendocrine Tumors; Plasma Cell Dyscrasia; Healthy Control
Sponsors: University of Nebraska
Recruiting
-
Posted: November 8th, 2013, 3:00am GMT
Conditions: Uterine Sarcoma
Interventions: Drug: Cabozantinib; Drug: Placebo
Sponsors: European Organisation for Research and Treatment of Cancer - EORTC; Gynecologic Oncology Group; NHS Greater Glasgow and Clyde
Active, not recruiting
-
Posted: October 1st, 2013, 2:00am GMT
Conditions: Osteosarcoma; Neuroblastoma
Interventions: Genetic: GD2 T cells; Biological: VZV vaccine; Drug: Fludarabine; Drug: Cyclophosphamide
Sponsors: Baylor College of Medicine; National Cancer Institute (NCI); Center for Cell and Gene Therapy, Baylor College of Medicine; The Methodist Hospital Research Institute
Active, not recruiting
-
Posted: September 5th, 2013, 2:00am GMT
Conditions: Endometrial Adenosquamous Carcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Mixed Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Metastatic Endometrioid Adenocarcinoma; Recurrent Uterine Corpus Cancer; Stage IV Uterine Corpus Cancer AJCC v7; Stage IVA Uterine Corpus Cancer AJCC v7; Stage IVB Uterine Corpus Cancer AJCC v7; Uterine Corpus Carcinosarcoma
Interventions: Drug: Cabozantinib S-malate; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: July 11th, 2013, 2:00am GMT
Conditions: Sarcoma
Interventions: Drug: KCP-330
Sponsors: Karyopharm Therapeutics Inc
Completed
-
Posted: May 29th, 2013, 2:00am GMT
Conditions: Newly Diagnosed Ewing Sarcoma
Interventions: Drug: Cyclophosphamide; Device: Doxorubicin; Drug: Vincristine; Drug: Ifosfamide; Drug: Etoposide; Procedure: Surgery; Radiation: Radiation Therapy*; Drug: Temozolomide; Drug: Irinotecan; Drug: Mesna; Drug: Dexrazoxane; Drug: G-CSF
Sponsors: Memorial Sloan Kettering Cancer Center
Active, not recruiting
-
Posted: May 21st, 2013, 2:00am GMT
Conditions: Ewing Sarcoma; Rhabdomyosarcoma
Interventions: Drug: Olaparib; Drug: Temozolomide; Drug: Irinotecan
Sponsors: Massachusetts General Hospital
Active, not recruiting
-
Posted: March 5th, 2013, 3:00am GMT
Conditions: Refractory and/or Relapsed Metastatic Solid Tumors
Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Radiation: low dose total body irradiation; Drug: Melphalan; Drug: Tacrolimus
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting
-
Posted: February 15th, 2013, 3:00am GMT
Conditions: Rare Disorders; Undiagnosed Disorders; Disorders of Unknown Prevalence; Cornelia De Lange Syndrome; Prenatal Benign Hypophosphatasia; Perinatal Lethal Hypophosphatasia; Odontohypophosphatasia; Adult Hypophosphatasia; Childhood-onset Hypophosphatasia; Infantile Hypophosphatasia; Hypophosphatasia; Kabuki Syndrome; Bohring-Opitz Syndrome; Narcolepsy Without Cataplexy; Narcolepsy-cataplexy; Hypersomnolence Disorder; Idiopathic Hypersomnia Without Long Sleep Time; Idiopathic Hypersomnia With Long Sleep Time; Idiopathic Hypersomnia; Kleine-Levin Syndrome; Kawasaki Disease; Leiomyosarcoma; Leiomyosarcoma of the Corpus Uteri; Leiomyosarcoma of the Cervix Uteri; Leiomyosarcoma of Small Intestine; Acquired Myasthenia Gravis; Addison Disease; Hyperacusis (Hyperacousis); Juvenile Myasthenia Gravis; Transient Neonatal Myasthenia Gravis; Williams Syndrome; Lyme Disease; Myasthenia Gravis; Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome); Isolated Klippel-Feil Syndrome; Frasier Syndrome; Denys-Drash Syndrome; Beckwith-Wiedemann Syndrome; Emanuel Syndrome; Isolated Aniridia; Axenfeld-Rieger Syndrome; Aniridia-intellectual Disability Syndrome; Aniridia - Renal Agenesis - Psychomotor Retardation; Aniridia - Ptosis - Intellectual Disability - Familial Obesity; Aniridia - Cerebellar Ataxia - Intellectual Disability; Aniridia - Absent Patella; Aniridia; Peters Anomaly - Cataract; Peters Anomaly; Potocki-Shaffer Syndrome; Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11; Silver-Russell Syndrome Due to Imprinting Defect of 11p15; Silver-Russell Syndrome Due to 11p15 Microduplication; Syndromic Aniridia; WAGR Syndrome; Wolf-Hirschhorn Syndrome; 4p16.3 Microduplication Syndrome; 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome; Autosomal Recessive Stickler Syndrome; Stickler Syndrome Type 2; Stickler Syndrome Type 1; Stickler Syndrome; Mucolipidosis Type 4; X-linked Spinocerebellar Ataxia Type 4; X-linked Spinocerebellar Ataxia Type 3; X-linked Intellectual Disability - Ataxia - Apraxia; X-linked Progressive Cerebellar Ataxia; X-linked Non Progressive Cerebellar Ataxia; X-linked Cerebellar Ataxia; Vitamin B12 Deficiency Ataxia; Toxic Exposure Ataxia; Unclassified Autosomal Dominant Spinocerebellar Ataxia; Thyroid Antibody Ataxia; Sporadic Adult-onset Ataxia of Unknown Etiology; Spinocerebellar Ataxia With Oculomotor Anomaly; Spinocerebellar Ataxia With Epilepsy; Spinocerebellar Ataxia With Axonal Neuropathy Type 2; Spinocerebellar Ataxia Type 8; Spinocerebellar Ataxia Type 7; Spinocerebellar Ataxia Type 6; Spinocerebellar Ataxia Type 5; Spinocerebellar Ataxia Type 4; Spinocerebellar Ataxia Type 37; Spinocerebellar Ataxia Type 36; Spinocerebellar Ataxia Type 35; Spinocerebellar Ataxia Type 34; Spinocerebellar Ataxia Type 32; Spinocerebellar Ataxia Type 31; Spinocerebellar Ataxia Type 30; Spinocerebellar Ataxia Type 3; Spinocerebellar Ataxia Type 29; Spinocerebellar Ataxia Type 28; Spinocerebellar Ataxia Type 27; Spinocerebellar Ataxia Type 26; Spinocerebellar Ataxia Type 25; Spinocerebellar Ataxia Type 23; Spinocerebellar Ataxia Type 22; Spinocerebellar Ataxia Type 21; Spinocerebellar Ataxia Type 20; Spinocerebellar Ataxia Type 2; Spinocerebellar Ataxia Type 19/22; Spinocerebellar Ataxia Type 18; Spinocerebellar Ataxia Type 17; Spinocerebellar Ataxia Type 16; Spinocerebellar Ataxia Type 15/16; Spinocerebellar Ataxia Type 14; Spinocerebellar Ataxia Type 13; Spinocerebellar Ataxia Type 12; Spinocerebellar Ataxia Type 11; Spinocerebellar Ataxia Type 10; Spinocerebellar Ataxia Type 1 With Axonal Neuropathy; Spinocerebellar Ataxia Type 1; Spinocerebellar Ataxia - Unknown; Spinocerebellar Ataxia - Dysmorphism; Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature; Spasticity-ataxia-gait Anomalies Syndrome; Spastic Ataxia With Congenital Miosis; Spastic Ataxia - Corneal Dystrophy; Spastic Ataxia; Rare Hereditary Ataxia; Rare Ataxia; Recessive Mitochondrial Ataxia Syndrome; Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature; Posterior Column Ataxia - Retinitis Pigmentosa; Post-Stroke Ataxia; Post-Head Injury Ataxia; Post Vaccination Ataxia; Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract; Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus; Non-hereditary Degenerative Ataxia; Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity; Olivopontocerebellar Atrophy - Deafness; NARP Syndrome; Myoclonus - Cerebellar Ataxia - Deafness; Multiple System Atrophy, Parkinsonian Type; Multiple System Atrophy, Cerebellar Type; Multiple System Atrophy; Maternally-inherited Leigh Syndrome; Machado-Joseph Disease Type 3; Machado-Joseph Disease Type 2; Machado-Joseph Disease Type 1; Leigh Syndrome; Late-onset Ataxia With Dementia; Infection or Post Infection Ataxia; GAD Ataxia; Hereditary Episodic Ataxia; Gliadin/Gluten Ataxia; Friedreich Ataxia; Fragile X-associated Tremor/Ataxia Syndrome; Familial Paroxysmal Ataxia; Exposure to Medications Ataxia; Episodic Ataxia With Slurred Speech; Episodic Ataxia Unknown Type; Episodic Ataxia Type 7; Episodic Ataxia Type 6; Episodic Ataxia Type 5; Episodic Ataxia Type 4; Episodic Ataxia Type 3; Episodic Ataxia Type 1; Epilepsy and/or Ataxia With Myoclonus as Major Feature; Early-onset Spastic Ataxia-neuropathy Syndrome; Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity; Early-onset Cerebellar Ataxia With Retained Tendon Reflexes; Early-onset Ataxia With Dementia; Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia; Dilated Cardiomyopathy With Ataxia; Cataract - Ataxia - Deafness; Cerebellar Ataxia, Cayman Type; Cerebellar Ataxia With Peripheral Neuropathy; Cerebellar Ataxia - Hypogonadism; Cerebellar Ataxia - Ectodermal Dysplasia; Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss; Brain Tumor Ataxia; Brachydactyly - Nystagmus - Cerebellar Ataxia; Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia; Autosomal Recessive Syndromic Cerebellar Ataxia; Autosomal Recessive Spastic Ataxia With Leukoencephalopathy; Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay; Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria; Autosomal Recessive Spastic Ataxia; Autosomal Recessive Metabolic Cerebellar Ataxia; Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine; Autosomal Recessive Ataxia, Beauce Type; Autosomal Recessive Ataxia Due to Ubiquinone Deficiency; Autosomal Recessive Ataxia Due to PEX10 Deficiency; Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia; Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency; Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency; Autosomal Recessive Congenital Cerebellar Ataxia; Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome; Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity; Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency; Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect; Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion; Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation; Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness; Autosomal Recessive Cerebellar Ataxia; Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly; Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation; Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy; Autosomal Dominant Spastic Ataxia Type 1; Autosomal Dominant Spastic Ataxia; Autosomal Dominant Optic Atrophy; Ataxia-telangiectasia Variant; Ataxia-telangiectasia; Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy; Autosomal Dominant Cerebellar Ataxia Type 4; Autosomal Dominant Cerebellar Ataxia Type 3; Autosomal Dominant Cerebellar Ataxia Type 2; Autosomal Dominant Cerebellar Ataxia Type 1; Autosomal Dominant Cerebellar Ataxia; Ataxia-telangiectasia-like Disorder; Ataxia With Vitamin E Deficiency; Ataxia With Dementia; Ataxia - Oculomotor Apraxia Type 1; Ataxia - Other; Ataxia - Genetic Diagnosis - Unknown; Acquired Ataxia; Adult-onset Autosomal Recessive Cerebellar Ataxia; Alcohol Related Ataxia; Multiple Endocrine Neoplasia; Multiple Endocrine Neoplasia Type II; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Multiple Endocrine Neoplasia, Type IV; Multiple Endocrine Neoplasia, Type 3; Multiple Endocrine Neoplasia (MEN) Syndrome; Multiple Endocrine Neoplasia Type 2B; Multiple Endocrine Neoplasia Type 2A; Atypical Hemolytic Uremic Syndrome; Atypical HUS; Wiedemann-Steiner Syndrome; Breast Implant-Associated Anaplastic Large Cell Lymphoma; Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA); Hemophagocytic Lymphohistiocytosis; Behcet's Disease; Alagille Syndrome; Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD); Lowe Syndrome; Pitt Hopkins Syndrome; 1p36 Deletion Syndrome; Jansen Type Metaphyseal Chondrodysplasia; Cockayne Syndrome; Chronic Recurrent Multifocal Osteomyelitis; CRMO; Malan Syndrome; Hereditary Sensory and Autonomic Neuropathy Type Ie; VCP Disease; Hypnic Jerking; Sleep Myoclonus; Mollaret Meningitis; Recurrent Viral Meningitis; CRB1; Leber Congenital Amaurosis; Retinitis Pigmentosa; Rare Retinal Disorder; KCNMA1-Channelopathy; Primary Biliary Cirrhosis; ZMYND11; Transient Global Amnesia; Glycogen Storage Disease; Alstrom Syndrome; White Sutton Syndrome; DNM1; EIEE31; Myhre Syndrome; Recurrent Respiratory Papillomatosis; Laryngeal Papillomatosis; Tracheal Papillomatosis; Refsum Disease; Nicolaides Baraitser Syndrome; Leukodystrophy; Tango2; Cauda Equina Syndrome; Rare Gastrointestinal Disorders; Achalasia-Addisonian Syndrome; Achalasia Cardia; Achalasia Icrocephaly Syndrome; Anal Fistula; Congenital Sucrase-Isomaltase Deficiency; Eosinophilic Gastroenteritis; Idiopathic Gastroparesis; Hirschsprung Disease; Rare Inflammatory Bowel Disease; Intestinal Pseudo-Obstruction; Scleroderma; Short Bowel Syndrome; Sacral Agenesis; Sacral Agenesis Syndrome; Caudal Regression; Scheuermann Disease; SMC1A Truncated Mutations (Causing Loss of Gene Function); Cystinosis; Juvenile Nephropathic Cystinosis; Nephropathic Cystinosis; Kennedy Disease; Spinal Bulbar Muscular Atrophy; Warburg Micro Syndrome; Mucolipidoses; Mitochondrial Diseases; Mitochondrial Aminoacyl-tRNA Synthetases; Mt-aaRS Disorders; Hypertrophic Olivary Degeneration; Non-Ketotic Hyperglycinemia; Fish Odor Syndrome; Halitosis; Isolated Congenital Asplenia; Lambert Eaton (LEMS); Biliary Atresia; STAG1 Gene Mutation; Coffin Lowry Syndrome; Borjeson-Forssman-Lehman Syndrome; Blau Syndrome; Arginase 1 Deficiency; HSPB8 Myopathy; Beta-Mannosidosis; TBX4 Syndrome; DHDDS Gene Mutations; MAND-MBD5-Associated Neurodevelopmental Disorder; Constitutional Mismatch Repair Deficiency (CMMRD); SPATA5 Disorder; SPATA5L1 Related Disorder
Sponsors: Sanford Health; National Ataxia Foundation; International WAGR Syndrome Association; 4p- Support Group; ML4 Foundation; Cornelia de Lange Syndrome Foundation; Stickler Involved People; Kawasaki Disease Foundation; Klippel-Feil Syndrome Alliance; Klippel-Feil Syndrome Freedom; Hyperacusis Research Limited; Hypersomnia Foundation; Kabuki Syndrome Network; Kleine-Levin Syndrome Foundation; Leiomyosarcoma Direct Research Foundation; Marinesco-Sjogren Syndrome Support Group - NORD; Mucolipidosis Type IV (ML4) Foundation; People with Narcolepsy 4 People with Narcolepsy (PWN4PWN); Soft Bones Incorporated; American Multiple Endocrine Neoplasia Support; Atypical Hemolytic Uremic Syndrome Foundation; All Things Kabuki; Wiedemann-Steiner Syndrome Foundation; Breast Implant Victim Advocates; PROS Foundation; American Behcet's Disease Association; Alstrom United Kingdom; Athymia; Curing Retinal Blindness Foundation; HSAN1E Society; 1p36 Deletion Support and Awareness; The Alagille Syndrome Alliance; Autoinflammatory Alliance; Beyond Batten Disease Foundation; Bohring-Opitz Syndrome Foundation, INC; Cockayne Syndrome Network (Share and Care); CRMO Foundation; Cure VCP Disease,INC; FOD Support; Cystinosis Research Foundation; Global DARE Foundation; Hypnic Jerk-Sleep Myoclonus Support Group; Jansen's Foundation; KCNMA1 Channelopathy International Advocacy Foundation; Kawasaki Disease Foundation Australia; Life with LEMS Foundation; Lowe Syndrome Association; The Malan Syndrome Foundation; Maple Syrup Urine Disease Family Support Group; International Association for Muscle Glycogen Storage Disease (IamGSD); Myhre Syndrome Foundation; DNM1 Families; Nicolaides Baraitser Syndrome (NCBRS) Worldwide Foundation; The PBCers Organization; Pitt Hopkins Research Foundation; Recurrent Meningitis Association; Recurrent Respiratory Papillomatosis Foundation; Remember the Girls; Smith-Kingsmore Syndrome Foundation; SPG Research Foundation; Team Telomere; Transient Global Amnesia Project; The Charlotte & Gwenyth Gray Foundation; The Cute Syndrome Foundation; The Maddi Foundation; White Sutton Syndrome Foundation; Zmynd11 Gene Disorder; Cauda Equina Foundation, Inc; Tango2 Research Foundation; Noah's Hope - Hope4Bridget Foundation; Project Sebastian; SMC1A Epilepsy Foundation; International Foundation for Gastrointestinal Disorders; Endosalpingiosis Foundation, Inc; International Sacral Agenesis/Caudal Regression Association (ISACRA); Scheuermann's Disease Fund; Batten Disease Support and Research Association; Kennedy's Disease Association; Cure Mito Foundation; Warburg Micro Research Foundation; Cure Mucolipidosis; Riaan Research Initiative; CureARS A NJ Nonprofit Corporation; CACNA1H Alliance; IMBS Alliance; SHINE-Syndrome Foundaion; Non- Ketotic Hyperglycinemia (NKH) Crusaders; Hypertrophic Olivary Degeneration Association (HODA); National Organization for Disorders of the Corpus Callosum (NODCC); Team4Travis; Taylor's Tale Foundation; Lambert Eaton (LEMS) Family Association; BARE Inc; STAG1 Gene Foundation; Coffin Lowry Syndrome Foundation; BLFS Incorporate; Aniridia North America; Cure Blau Syndrome Foundation; ARG1D Foundation; CURE HSPB8 Myopathy; International Society of Mannosidosis and Related Disorders; TBX4Life; Cure DHDDS; MANDKind Foundation; Krishnan Family Foundation; SPATA Foundation
Recruiting
-
Posted: February 13th, 2013, 3:00am GMT
Conditions: Hodgkin Lymphoma in Remission; Leukemia in Remission; Lymphoblastic Lymphoma; Osteosarcoma; Recurrent Leukemia; Recurrent Lymphoma; Recurrent Malignant Neoplasm
Interventions: Other: Assessment of Therapy Complications; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting
-
Posted: January 21st, 2013, 3:00am GMT
Conditions: Glioma; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Melanoma; Sarcoma
Interventions: Procedure: Biospecimen Collection; Other: Genetic Testing; Other: Medical Chart Review
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: December 24th, 2012, 3:00am GMT
Conditions: Refractory Soft Tissue Sarcomas
Interventions: Drug: Cabozantinib
Sponsors: National Cancer Institute (NCI)
Completed
-
Posted: December 10th, 2012, 3:00am GMT
Conditions: Sarcoma
Interventions: Drug: Bevacizumab; Drug: Doxorubicin; Radiation: Radiation Therapy
Sponsors: Massachusetts General Hospital
Active, not recruiting
-
Posted: August 9th, 2012, 2:00am GMT
Conditions: Glioma; Neuroectodermal Tumors, Primitive; Wilms Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Osteosarcoma; Retinoblastoma
Interventions: Drug: Metronomic Cyclophosphamide; Drug: Thalidomide
Sponsors: Washington University School of Medicine
Completed
-
Posted: March 5th, 2012, 3:00am GMT
Conditions: Metastatic Solid Tumors
Interventions: Drug: PZP115891, PCI-24781
Sponsors: Pamela Munster; Pharmacyclics LLC.; Novartis; Xynomic Pharmaceuticals, Inc.; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease
Active, not recruiting
-
Posted: January 6th, 2012, 3:00am GMT
Conditions: Ewing's Family Tumors; Renal Tumors; Hepatoblastoma; Rhabdomyosarcoma; Soft Tissue Sarcoma; Primary Malignant Brain Neoplasms; Retinoblastoma; Medulloblastoma; Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET); Atypical Teratoid/Rhabdoid Tumor (AT/RT); CNS Tumors; Germ Cell Tumors
Interventions: Drug: Ifosfamide; Drug: Etoposide; Drug: Mesna; Biological: G-CSF; Drug: Busulfan; Drug: Melphalan; Drug: Thiotepa; Biological: Autologous stem cell infusion; Radiation: Radiation; Drug: Carboplatin; Drug: Paclitaxel; Procedure: Leukapheresis; Drug: Anti-seizure prophylaxis; Drug: Ursodiol
Sponsors: Masonic Cancer Center, University of Minnesota
Completed
-
Posted: July 1st, 2011, 2:00am GMT
Conditions: Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic Syndromes; Lymphoma; Neuroblastoma; Rhabdomyosarcoma
Interventions: Biological: CD3-depleted/CD56+ selected natural killer cells collected from apheresis products
Sponsors: University Hospital, Basel, Switzerland
Completed
-
Posted: April 18th, 2011, 2:00am GMT
Conditions: Bone Cancer; Chondrosarcoma; Ewing's Sarcoma; Osteosarcoma; Rhabdomyosarcoma; Bone Necrosis; Bone Sarcoma; Osteomyelitis
Interventions: Drug: Feraheme; Procedure: Magnetic Resonance Imaging (MRI) scan
Sponsors: Heike E Daldrup-Link
Completed
-
Posted: April 23rd, 2010, 2:00am GMT
Conditions: Sarcoma; Endocrine Tumors; Neuroblastoma; Retinoblastoma; Renal Cancer
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: December 9th, 2009, 3:00am GMT
Conditions: Sarcoma
Interventions: Drug: PCI-24781; Drug: Doxorubicin; Drug: GCSF
Sponsors: Massachusetts General Hospital; Dana-Farber Cancer Institute; Brigham and Women's Hospital; Pharmacyclics LLC.
Completed
-
Posted: July 21st, 2009, 2:00am GMT
Conditions: Sarcoma, Alveolar Soft Part
Interventions: Drug: AZD2171
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: May 14th, 2009, 2:00am GMT
Conditions: Sarcoma
Interventions: Genetic: Autologous HER2-specific T cells; Drug: Fludarabine; Drug: Cyclophosphamide; Genetic: Autologous CAR Positive T cells
Sponsors: Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine; The Methodist Hospital Research Institute; Cancer Prevention Research Institute of Texas
Active, not recruiting
-
Posted: May 12th, 2009, 2:00am GMT
Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Central Nervous System Neoplasm; Ewing Sarcoma; Germ Cell Tumor; Leukemia; Lymphoma; Malignant Neoplasm; Neuroblastoma; Osteosarcoma; Retinoblastoma; Rhabdoid Tumor; Rhabdomyosarcoma; Soft Tissue Sarcoma
Interventions: Other: Cytology Specimen Collection Procedure; Other: Laboratory Biomarker Analysis
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting
-
Posted: March 19th, 2008, 2:00am GMT
Conditions: Solid Tumor; Adult Central Nervous System Germ Cell Tumor; Adult Rhabdomyosarcoma; Childhood Central Nervous System Germ Cell Tumor; Childhood Soft Tissue Sarcoma; Ewing Sarcoma; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Ovarian Mixed Germ Cell Tumor; Previously Untreated Childhood Rhabdomyosarcoma; Recurrent Adult Brain Tumor; Recurrent Adult Soft Tissue Sarcoma; Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Cerebellar Astrocytoma; Recurrent Childhood Cerebral Astrocytoma; Recurrent Childhood Ependymoma; Recurrent Childhood Malignant Germ Cell Tumor; Recurrent Childhood Medulloblastoma; Recurrent Childhood Pineoblastoma; Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor; Recurrent Childhood Visual Pathway and Hypothalamic Glioma; Recurrent Childhood Visual Pathway Glioma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Extragonadal Germ Cell Tumor; Recurrent Extragonadal Non-seminomatous Germ Cell Tumor; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Neuroblastoma; Recurrent Ovarian Germ Cell Tumor; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: busulfan; Drug: melphalan; Drug: topotecan hydrochloride; Other: laboratory biomarker analysis; Biological: filgrastim; Procedure: autologous hematopoietic stem cell transplantation; Other: pharmacological study; Procedure: autologous bone marrow transplantation
Sponsors: City of Hope Medical Center
Active, not recruiting
-
Posted: December 24th, 2007, 3:00am GMT
Conditions: Head and Neck Cancers
Sponsors: Memorial Sloan Kettering Cancer Center; American Cancer Society, Inc.
Active, not recruiting
-
Posted: July 30th, 2007, 2:00am GMT
Conditions: Spinal Neoplasms
Interventions: Radiation: Radiation Therapy
Sponsors: M.D. Anderson Cancer Center
Active, not recruiting
-
Posted: July 4th, 2007, 2:00am GMT
Conditions: Chondrosarcoma
Interventions: Procedure: Proton Beam Therapy
Sponsors: M.D. Anderson Cancer Center
Active, not recruiting
-
Posted: May 7th, 2007, 2:00am GMT
Conditions: Sarcoma
Interventions: Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: methotrexate; Drug: zoledronic acid; Procedure: conventional surgery
Sponsors: UNICANCER; Novartis; Chugai Pharmaceutical; National Cancer Institute, France; SFCE; Ligue contre le cancer, France
Active, not recruiting
-
Posted: March 6th, 2007, 3:00am GMT
Conditions: Lung Cancer; Adult Soft Tissue Sarcoma; Colorectal Cancer; Bone Cancer; Ovarian Sarcoma; Melanoma; Colon Cancer; Rectal Cancer; Breast Cancer; Eye Cancer; Uterine Sarcoma
Interventions: Drug: interleukin-2; Drug: MAGE-12 peptide vaccine; Drug: Montanide ISA-51
Sponsors: National Cancer Institute (NCI)
Completed
-
Posted: March 5th, 2007, 3:00am GMT
Conditions: Childhood Soft Tissue Sarcoma; Childhood Liver Cancer; Bone Cancer; Brain Tumor; Kidney Tumor
Interventions: Drug: doxorubicin HCl liposome
Sponsors: National Cancer Institute (NCI)
Completed
-
Posted: March 5th, 2007, 3:00am GMT
Conditions: Epidemic Kaposi's Sarcoma; Recurrent Kaposi's Sarcoma
Interventions: Drug: interleukin-12
Sponsors: National Cancer Institute (NCI)
Completed
-
Posted: June 21st, 2006, 2:00am GMT
Conditions: Kaposi s Sarcoma (KS)
Sponsors: National Cancer Institute (NCI)
Completed
-
Posted: August 5th, 2004, 2:00am GMT
Conditions: Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma
Interventions: Drug: Iodine I 131 MOAB 8H9; Drug: Iodine I 131 MOAB 8H9
Sponsors: Y-mAbs Therapeutics; Memorial Sloan Kettering Cancer Center
Terminated
-
Posted: November 15th, 2001, 3:00am GMT
Conditions: Breast Cancer; Prostate Cancer; Lung Cancer; Sarcoma; Melanoma
Sponsors: National Cancer Institute (NCI)
Enrolling by invitation
-
Posted: November 23rd, 2000, 3:00am GMT
Conditions: HIV; Kaposi's Sarcoma; Lymphomas; Multicentric Castleman's Disease; Primary Effusion Lymphoma
Sponsors: National Cancer Institute (NCI)
Recruiting